GG
Schedule 13G filing
GordonMD Global Investments LP disclosed a 17.5% stake in Pyxis Oncology, Inc. (PYXS)
GordonMD Global Investments LP reported owning 17.5% of Pyxis Oncology, Inc. (PYXS) (27,988,714 shares) in a Schedule 13G filed Oct 2, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More PYXS insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.